Allogene Therapeutics Cash from Operations (TTM) Insights

Allogene Therapeutics Inc (ALLO)

3.40 -0.07 (-2.02%) USD | NASDAQ | Apr 22, 16:00

3.395 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	-237.73M
September 30, 2023	-246.12M
June 30, 2023	-238.25M
March 31, 2023	-218.92M
December 31, 2022	-220.52M
September 30, 2022	-203.86M
June 30, 2022	-205.08M
March 31, 2022	-203.72M
December 31, 2021	-184.81M
September 30, 2021	-149.35M
June 30, 2021	-138.06M

Date	Value
March 31, 2021	-123.61M
December 31, 2020	-115.09M
September 30, 2020	-155.38M
June 30, 2020	-149.73M
March 31, 2020	-147.90M
December 31, 2019	-137.35M
September 30, 2019	-108.56M
June 30, 2019	-93.76M
March 31, 2019	-74.91M
December 31, 2018	-44.65M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-246.12M

Minimum

Sep 2023

-93.76M

Maximum

Jun 2019

-172.52M

Average

-155.38M

Median

Sep 2020

Cash from Operations (TTM) Benchmarks